A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07101328
Phase 1, Recruiting
Active & Responsive
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Boston MA, New York NY, Toronto, Hamilton, Tampa FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07114601
Phase 1, Recruiting
New
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
for
Obesity
Location: Oxnard CA
Sponsor: Eli Lilly and Company
Sex: All
Age: 6 - 11
Code: NCT07817875
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Boston MA, Watertown MA, The Bronx NY, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07775300
Phase 3, Recruiting
New
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Daytona Beach FL, Dallas TX
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18 - 60
Code: NCT07808060
Phase 1, Recruiting
New
A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
for
Obesity, Overweight
Location: Daytona Beach FL, Dallas TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07808073
Phase 1, Recruiting
New
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease